Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
04/16/1998 | WO1998015266A1 Use of bisphenolic compounds to treat type ii diabetes |
04/16/1998 | WO1998015265A1 Colonic delivery of weak acid drugs |
04/16/1998 | WO1998015264A1 PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF THE HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN |
04/16/1998 | WO1998015263A2 A method for producing a microparticle |
04/16/1998 | WO1998015260A1 Wrinkling modifiers |
04/16/1998 | WO1998015196A1 Compositions for postgastrectomic mineral supply |
04/16/1998 | WO1998015178A1 Sordarin derivatives |
04/16/1998 | WO1998011229A3 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
04/16/1998 | WO1998011211A3 Method for using oligonucleotides having modified cpg dinucleosides |
04/16/1998 | WO1998009970A3 Alkylated rapamycin derivatives |
04/16/1998 | DE19642591A1 Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung New piperidine-ketocarboxylic acid derivatives, their preparation and application |
04/16/1998 | DE19642451A1 Aminothiophencarbonsäureamide Aminothiophencarbonsäureamide |
04/16/1998 | DE19642290A1 Use of non-peptide bradykinin antagonist in treating Alzheimer's disease |
04/16/1998 | DE19642284A1 Pyrazolinone zur Behandlung von Potenzstörungen Pyrazolinones for the treatment of erectile dysfunction |
04/16/1998 | DE19642255A1 Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten Use of 1-benzyl-3- (substituted-heteroaryl) -kondensierten pyrazole derivatives |
04/16/1998 | DE19640791A1 Glycokonjugate als Inhibitoren der viralen Zelladhäsion Glycoconjugates as inhibitors of viral cell adhesion |
04/16/1998 | CA2268874A1 Use of bisphenolic compounds to treat type ii diabetes |
04/16/1998 | CA2268172A1 Thio acid derived monocyclic n-heterocyclics as anticoagulants |
04/16/1998 | CA2268164A1 New serotonin 5-ht1f agonists |
04/16/1998 | CA2267967A1 Method for inhibiting stress-activated protein kinases |
04/16/1998 | CA2267943A1 5-heteroatom-containing alkyl substituted-3-oxo-pyrido(1,2-a) benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders |
04/16/1998 | CA2267930A1 A method for producing a microparticle |
04/16/1998 | CA2267835A1 1,4-disubstituted piperazines |
04/16/1998 | CA2267767A1 Radiopharmaceuticals for imaging infection and inflammation |
04/16/1998 | CA2267691A1 N-substituted azaheterocyclic compounds |
04/16/1998 | CA2267500A1 N-substituted azaheterocyclic compounds |
04/16/1998 | CA2267381A1 Method for the treatment of neurological or neuropsychiatric disorders |
04/16/1998 | CA2267154A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
04/16/1998 | CA2267129A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis |
04/16/1998 | CA2267067A1 Promoter for smooth muscle cell expression |
04/16/1998 | CA2266773A1 Use of a nk-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
04/16/1998 | CA2266376A1 1h-pyrido¬3,4-b|indole-4-carboxamide derivatives, preparation and application thereof in therapeutics |
04/16/1998 | CA2265550A1 Methods and compositions for generating angiostatin |
04/16/1998 | CA2264637A1 Colonic delivery of weak acid drugs |
04/16/1998 | CA2242525A1 Compositions and methods for modulating melanin production |
04/16/1998 | CA2239308A1 New combination |
04/15/1998 | EP0835888A2 Non-crosslinked anion exchange resin and pharmaceutical composition containing same |
04/15/1998 | EP0835878A1 Benzo (b) thiophene compounds, intermediates, formulations, and methods |
04/15/1998 | EP0835872A1 Benzo [b] thiophene compounds, intermediates, formulations, and methods |
04/15/1998 | EP0835871A1 Benzo [b] thiophene compounds, intermediates, formulations, and methods |
04/15/1998 | EP0835869A2 New serotonin 5-HT1F agonists |
04/15/1998 | EP0835868A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
04/15/1998 | EP0835867A1 1-Aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods |
04/15/1998 | EP0835859A1 Process for producing valproic acid |
04/15/1998 | EP0835659A1 Use of non-peptidic bradykinin antagonists in the preparation of medicaments for the treatment and prevention of Alzheimer's disease |
04/15/1998 | EP0835658A2 Enhancing and stabilizing agent of the activity of bifidus factor |
04/15/1998 | EP0835657A1 Injectable composition |
04/15/1998 | EP0835656A1 Combination drug containing tramadol and a calcium channel antagonist |
04/15/1998 | EP0835655A1 Antibacterial/bactericidal/antiseptic agent, dermatologic preparation, and detergent composition |
04/15/1998 | EP0835652A1 Use of at least one glycol in the solubilisation of melatonin in water and compositions containing them |
04/15/1998 | EP0835650A1 Use of oxazolidinon derivatives as antipenetrant agents in a cosmetic and/or dermatologic composition |
04/15/1998 | EP0835613A2 Stable emulsions and dry powder from mixtures of fat-soluble vitamins, their process of preparation and their use |
04/15/1998 | EP0835319A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1 |
04/15/1998 | EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
04/15/1998 | EP0835258A1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
04/15/1998 | EP0835257A1 Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds |
04/15/1998 | EP0835255A1 Novel substituted azacyclic compounds |
04/15/1998 | EP0835254A1 Oxazolidinone derivatives, their preparation and therapeutical use |
04/15/1998 | EP0835253A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
04/15/1998 | EP0835252A1 Triazole antifungal agents |
04/15/1998 | EP0835251A1 Process for the production of lipoic acid |
04/15/1998 | EP0835246A1 Aromatic compounds and pharmaceutical compositions containing them |
04/15/1998 | EP0835244A1 Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors |
04/15/1998 | EP0835135A2 Platelet-specific chimeric immunoglobulin and methods of use therefor |
04/15/1998 | EP0835127A1 Compositions and methods using myelin-associated glycoprotein (mag) and inhibitors thereof |
04/15/1998 | EP0835125A1 Cd4-derived peptides that inhibit immune responses |
04/15/1998 | EP0835120A1 Pharmaceutical compositions containing herbal-based active ingredients; method for preparing same and uses of same for medical and veterinary purposes |
04/15/1998 | EP0835118A2 Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin |
04/15/1998 | EP0835117A1 Ether derivatives of pseudopterosin |
04/15/1998 | EP0835116A1 Compounds and pharmaceutical compositions containing them |
04/15/1998 | EP0835115A1 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists |
04/15/1998 | EP0835114A1 Pharmaceutical combined preparation, kit and method for hormonal contraception |
04/15/1998 | EP0835113A1 Dehydroepiandrosterone derivatives for preventing progressive tissue necrosis reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
04/15/1998 | EP0835112A2 Medicament preparations containing tumour-inhibiting ruthenium (iii) complexes |
04/15/1998 | EP0835111A2 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
04/15/1998 | EP0835110A1 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
04/15/1998 | EP0835109A1 Pyridinone-thrombin inhibitors |
04/15/1998 | EP0835108A1 Use of lamellarin-class alkaloids in methods of treatment |
04/15/1998 | EP0835107A1 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence |
04/15/1998 | EP0835106A1 Method of treating renal disease using an ace inhibitor and an aii antagonist |
04/15/1998 | EP0835105A1 Pharmaceutical amiodarone composition for parenteral delivery |
04/15/1998 | EP0835104A1 Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis |
04/15/1998 | EP0835098A1 New, stable medicinal compositions for generating propellant-free aerosols |
04/15/1998 | EP0835092A1 Composition and treatment for baldness |
04/15/1998 | EP0821686A4 Novel porphyrins and porphyrin synthesis techniques |
04/15/1998 | EP0797442A4 Treatment of optic neuritis |
04/15/1998 | EP0714388B1 Vasoconstrictive substituted aryloxyalkyl diamines |
04/15/1998 | EP0711275B1 (thio)carbimidinic acid derivatives and medicaments containing the same |
04/15/1998 | EP0699204B1 Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
04/15/1998 | EP0696200A4 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
04/15/1998 | EP0678025B1 Transdermal treatment of cancer with water-insoluble s-camptothecin of the closed lactone ring form |
04/15/1998 | EP0667771B1 Antitumour compositions containing taxane derivatives |
04/15/1998 | EP0666749B1 ENANTIOMERICALLY PURE beta-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY |
04/15/1998 | EP0665745B1 Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline ingredients, and processs for producing the same |
04/15/1998 | EP0650331B1 Food products containing benzimidazole |
04/15/1998 | EP0550532B1 Dextrin sulfates as anti hiv-1 agents and composition thereof |
04/15/1998 | CN1179162A Heterocycle-fused thiazole derivatives |
04/15/1998 | CN1179160A Process and crystal form of 2-methyl -thieno -benzodiazepine |
04/15/1998 | CN1179159A Guanine derivatives |
04/15/1998 | CN1179158A 4 -amino -3 -acylnaphthyridine derivatives |